Manufacturer record
YL Pharma Baddi: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by YL Pharma Baddi (Himachal Pradesh) was declared Not of Standard Quality in May 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: YLT25005, Acelofenac & Paracetamol Tablets (ACELOZAL-P) (exp Dec 2026). DTL Baddi Distt Solan HP (state lab) found it not of standard quality: The sample does not conforms to Patent & Proprietary in repect to the Assay of Aceclofenac. Listed in the May 2025 alert.
Records by type
1 record linked to YL Pharma Baddi in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Acelofenac & Paracetamol Tablets (ACELOZAL-P) | Batch YLT25005Mfg Jan 2025 · Exp Dec 2026 | The sample does not conforms to Patent & Proprietary in repect to the Assay of Aceclofenac.Assay | DTL Baddi Distt Solan HPState lab | May 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.